The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

GlaxoSmithKline is opening a £10 million artificial intelligence (AI) research hub in King’s Cross, London, according to a press report. The area is being reimagined as a life sciences and ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or ...

GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I've ...

This European review of the prefilled syringe follows GSK's receipt of approval from the US Food & Drug Administration on January 8. GSK is also investigating submission of the new presentation to ...

The UK drugmaker plans to bring the IDRx drug into late stage trials later this year. GSK shares were little changed in early ...

To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...

Lacalle Pou “welcomed GSK's announcement of the opening of one ... The UK “encouraged exploring the cross-issuance of this bond in London to access the ample global capital funds present ...